Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A4

    
• • ·Information for Readers

    Page :A5

    

• Editorials

  • ·Ultrafiltration therapy for acute decompensated heart failure: Lessons learned from 2 major trials

    Page :799-803

    Amir Kazory, Claudio Ronco

    Plan Plan
  • ·Atypical is becoming typical in ST-elevation myocardial infarction presentation, but delays persist for women

    Page :804-805

    Charles V. Pollack

    

• Curriculum in Cardiology

  • ·Posttraumatic stress disorder and risk for coronary heart disease: A meta-analytic review

    Page :806-814

    Donald Edmondson, Ian M. Kronish, Jonathan A. Shaffer, Louise Falzon, Matthew M. Burg

    Résumé Résumé Plan Plan  

• Trial Design

  • ·A large-scale cluster randomized trial to determine the effects of community-based dietary sodium reduction—the China Rural Health Initiative Sodium Reduction Study

    Page :815-822

    Nicole Li, Lijing L. Yan, Wenyi Niu, Darwin Labarthe, Xiangxian Feng, Jingpu Shi, Jianxin Zhang, Ruijuan Zhang, Yuhong Zhang, Hongling Chu, Andrea Neiman, Michael Engelgau, Paul Elliott, Yangfeng Wu, Bruce Neal

    Résumé Résumé Plan Plan  
  • ·Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial

    Page :823

    Steven P. Marso, Neil R. Poulter, Steven E. Nissen, Michael A. Nauck, Bernard Zinman, Gilbert H. Daniels, Stuart Pocock, William M. Steinberg, Richard M. Bergenstal, Johannes F.E. Mann, Lasse Steen Ravn, Kirstine Brown Frandsen, Alan C. Moses, John B. Buse

    Résumé Résumé Plan Plan  
  • ·Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in Uncertain DES Candidates study

    Page :831-838

    Marco Valgimigli, Athanasios Patialiakas, Attila Thury, Salvatore Colangelo, Gianluca Campo, Matteo Tebaldi, Imre Ungi, Stefano Tondi, Marco Roffi, Alberto Menozzi, Nicoletta de Cesare, Roberto Garbo, Emanuele Meliga, Luca Testa, Henrique M. Gabriel, Flavio Airoldi, Marco Ferlini, Francesco Liistro, Antonio Dellavalle, Pascal Vranckx, Carlo Briguori

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Gender-specific ambulance priority and delays to primary percutaneous coronary intervention: A consequence of the patients' presentation or the management at the emergency medical communications center?

    Page :839-845

    Tor Melberg, Bjørg Kindervaag, Jan Rosland

    Résumé Résumé Plan Plan  
  • ·Recent temporal trends for first-time hospitalization for acute myocardial infarction. Treatment patterns and clinical outcome in a large cohort study

    Page :846-854

    Paolo Ortolani, Massimiliano Marino, Giovanni Melandri, Paolo Guastaroba, Alessandro Corzani, Elena Berti, Claudio Rapezzi, Rossana De Palma, Angelo Branzi

    Résumé Résumé Plan Plan  
  • ·New-onset atrial fibrillation predicts malignant arrhythmias in post–myocardial infarction patients—A Cardiac Arrhythmias and RIsk Stratification after acute Myocardial infarction (CARISMA) substudy

    Page :855

    Anne-Christine Huth Ruwald, Poul Erik Bloch Thomsen, Uffe Gang, Rikke Mørch Jørgensen, Heikki V. Huikuri, Christian Jons

    Résumé Résumé Plan Plan  
  • ·Warfarin use among older atrial fibrillation patients with non–ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy

    Page :864-870

    Emil L. Fosbol, Tracy Y. Wang, Shuang Li, Jonathan Piccini, Renato D. Lopes, Roger M. Mills, Winslow Klaskala, Laine Thomas, Matthew T. Roe, Eric D. Peterson

    Résumé Résumé Plan Plan  
  • ·Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation

    Page :871-878

    Nancy M. Allen LaPointe, Yuliya Lokhnygina, Gillian D. Sanders, Eric D. Peterson, Sana M. Al-Khatib

    Résumé Résumé Plan Plan  
  • ·Initiation of statin therapy after acute myocardial infarction is not associated with worsening depressive symptoms: Insights from the Prospective Registry Evaluating Outcomes After Myocardial Infarctions: Events and Recovery (PREMIER) and Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) registries

    Page :879-886

    Firas J. Al Badarin, John A. Spertus, Kensey L. Gosch, Donna M. Buchanan, Paul S. Chan

    Résumé Résumé Plan Plan  
  • ·Frailty and risk for heart failure in older adults: The health, aging, and body composition study

    Page :887-894

    Hassan Khan, Andreas P. Kalogeropoulos, Vasiliki V. Georgiopoulou, Anne B. Newman, Tamara B. Harris, Nicolas Rodondi, Douglas C. Bauer, Stephen B. Kritchevsky, Javed Butler

    Résumé Résumé Plan Plan  
  • ·Risk stratification for death and all-cause hospitalization in heart failure clinic outpatients

    Page :895

    Scott L. Hummel, Hussam H. Ghalib, David Ratz, Todd M. Koelling

    Résumé Résumé Plan Plan  
  • ·Risk factors associated with the incidence and progression of mitral annulus calcification: The multi-ethnic study of atherosclerosis

    Page :904-912

    Sammy Elmariah, Matthew J. Budoff, Joseph A.C. Delaney, Yasmin Hamirani, John Eng, Valentin Fuster, Richard A. Kronmal, Jonathan L. Halperin, Kevin D. O'Brien

    Résumé Résumé Plan Plan  
  • ·Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study

    Page :913-919

    Akshay Bagai, Paul W. Armstrong, Amanda Stebbins, Kenneth W. Mahaffey, Judith S. Hochman, W. Douglas Weaver, Manesh R. Patel, Christopher B. Granger, Renato D. Lopes

    Résumé Résumé Plan Plan  
  • ·Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: A randomized trial

    Page :920-926

    Francesco Liistro, Italo Porto, Paolo Angioli, Simone Grotti, Kenneth Ducci, Giovanni Falsini, Leonardo Bolognese

    Résumé Résumé Plan Plan  
  • ·Cardiac biomarker measurement after elective percutaneous coronary interventions in older patients: Insights from the National Cardiovascular Data Registry

    Page :927-934

    Tracy Y. Wang, Lisa A. McCoy, John C. Messenger, Megan L. Neely, Kalon K.L. Ho, Matthew T. Roe, H. Vernon Anderson

    Résumé Résumé Plan Plan  
  • ·Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

    Page :935

    Roberto Latini, Lidia Staszewsky, Jie-Lena Sun, M. Angelyn Bethel, Marcello Disertori, Steven M. Haffner, Rury R. Holman, Futien Chang, Thomas D. Giles, Aldo P. Maggioni, Guy E.H.M. Rutten, Eberhard Standl, Laine Thomas, Gianni Tognoni, Robert M. Califf, John J.V. McMurray

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Letter to the editor concerning the article by Kooiman et al

    Page :e41

    Yavuzer Koza, Muhammed Hakan Tas, Ziya Simsek

    
  • ·Reply to letter to the editor by Koza et al

    Page :e43

    Judith Kooiman, Pum A. le Haen, Gülcin Gezgin, Jean-Paul P.M. de Vries, D Boersma, Harald F.H. Brulez, Yvo W.J. Sijpkens, Aart J. van der Molen, Suzanne C. Cannegieter, Jaap F. Hamming, Menno V. Huisman